| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 208.894.190 | 196.210.205 | 159.241.331 | 170.786.371 | 174.735.967 | 143.182.000 | 157.368.861 | 181.776.180 | - | 78.056.754 |
| Total Income - EUR | 211.089.358 | 198.743.730 | 162.917.143 | 172.936.789 | 177.187.112 | 144.079.493 | 158.779.540 | 183.176.474 | - | 78.985.809 |
| Total Expenses - EUR | 210.377.646 | 197.991.087 | 164.375.500 | 173.142.596 | 176.793.167 | 143.555.623 | 158.107.853 | 182.395.430 | - | 117.301.516 |
| Gross Profit/Loss - EUR | 711.712 | 752.642 | -1.458.357 | -205.807 | 393.945 | 523.870 | 671.687 | 781.044 | - | -38.315.707 |
| Net Profit/Loss - EUR | 647.357 | 752.642 | -1.486.856 | -205.807 | 73.590 | 523.870 | 671.687 | 781.044 | - | -39.101.727 |
| Employees | 447 | 429 | 421 | 403 | 414 | 379 | 301 | 295 | - | 184 |
Check the financial reports for the company - Europharm Holding Sa
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.207.551 | 3.290.938 | 3.619.000 | 3.429.365 | 2.599.699 | 2.029.200 | 2.711.283 | 6.149.802 | - | 6.764.964 |
| Current Assets | 90.761.712 | 76.381.871 | 58.425.629 | 61.245.620 | 58.764.632 | 62.293.126 | 83.485.237 | 87.575.764 | - | 38.210.894 |
| Inventories | 20.642.901 | 16.575.961 | 14.876.528 | 17.072.253 | 16.973.891 | 9.685.579 | 16.223.459 | 11.624.561 | - | 2.364.776 |
| Receivables | 55.705.083 | 44.478.792 | 33.522.558 | 36.651.840 | 39.392.359 | 48.599.832 | 61.947.422 | 72.110.722 | - | 32.595.371 |
| Cash | 525.119 | 15.327.119 | 10.026.543 | 7.521.527 | 2.398.382 | 4.007.715 | 5.314.356 | 3.840.481 | - | 980.072 |
| Shareholders Funds | 20.467.794 | 20.589.837 | 17.517.980 | 16.990.687 | 16.735.233 | 16.941.842 | 17.237.827 | 18.072.351 | - | -20.147.504 |
| Social Capital | 13.136.823 | 13.002.845 | 12.782.815 | 12.548.228 | 12.305.217 | 12.071.939 | 11.804.232 | 11.840.855 | - | 11.738.974 |
| Debts | 72.366.793 | 58.979.970 | 44.294.363 | 47.890.362 | 44.789.066 | 47.520.831 | 69.247.917 | 75.940.908 | - | 64.819.279 |
| Income in Advance | 319.846 | 0 | 0 | 0 | 36.256 | 0 | 30.015 | 0 | - | 3.302 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Europharm Holding Sa